Skip to main content
. 2017 Jan 6;17(1):199–210. doi: 10.1007/s40268-016-0167-3
Some reports of adverse effects from mefloquine define a syndrome class characterized by symptoms of deliria.
This syndrome class is associated with additional symptoms including some that may be prodromal.